{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:38:45Z","timestamp":1790768325067,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:40:45Z","timestamp":1640202045000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Rectal cancer radiotherapy"],"prefix":"10.1016","volume":"26","author":[{"given":"V.","family":"Vendrely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rivin Del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jolnerowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Meillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chiavassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-A.","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cr\u00e9hanges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lemanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Peiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.11.002_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol Rev"},{"key":"10.1016\/j.canrad.2021.11.002_bib0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.dld.2017.01.152","article-title":"Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"49","author":"G\u00e9rard","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.canrad.2021.11.002_bib0160","doi-asserted-by":"crossref","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med;345(9):638-46.","DOI":"10.1056\/NEJMoa010580"},{"key":"10.1016\/j.canrad.2021.11.002_bib0165","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0170","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.11.002_bib0175","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/cncr.25943","article-title":"Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.11.002_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2003.09.032","article-title":"Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance","volume":"40","author":"Bosset","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.11.002_bib0185","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with folfirinox and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (Unicancer-Prodige 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (Rapido): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0195","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","article-title":"Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (Greccar-6)","volume":"34","author":"Lef\u00e8vre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/bjs.6470","article-title":"Non-operative management of rectal cancer after neoadjuvant chemoradiation","volume":"96","author":"Habr-Gama","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.canrad.2021.11.002_bib0210","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2021.11.002_bib0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2021.11.002_bib0220","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2468-1253(19)30410-8","article-title":"Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the Greccar 2 randomised trial","volume":"5","author":"Rullier","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0225","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the Accord 12\/0405 Prodige 2 randomized trial in rectal cancer","volume":"30","author":"G\u00e9rard","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0230","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.002_bib0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.canrad.2011.07.236","article-title":"[Rectal cancer: The radiation basis of radiotherapy, target volume]","volume":"15","author":"Bosset","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.11.002_bib0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on clinical target volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0245","article-title":"The International Commission on Radiation Units and, Measurements","volume":"10","year":"2010","journal-title":"J ICRU"},{"key":"10.1016\/j.canrad.2021.11.002_bib0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/0284186X.2014.975840","article-title":"Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud \u2013 Nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients","volume":"54","author":"G\u00e9rard","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2018.11.022","article-title":"Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study","volume":"108","author":"G\u00e9rard","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.11.002_bib0260","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ijrobp.2019.08.042","article-title":"Image-guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer","volume":"105","author":"Garant","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0265","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jjco\/hyy029","article-title":"Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity","volume":"48","author":"Wee","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0270","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/CCO.0000000000000306","article-title":"Technological advances in radiotherapy of rectal cancer: opportunities and challenges","volume":"28","author":"Appelt","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clon.2015.10.012","article-title":"Rectal radiotherapy? Intensity-modulated radiotherapy delivery, delineation and doses","volume":"28","author":"Teoh","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jrr\/rrw098","article-title":"A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma","volume":"58","author":"Huang","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2021.11.002_bib0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fonc.2017.00225","article-title":"Comparative analysis of efficacy, toxicity, and patient-reported outcomes in rectal cancer patients undergoing preoperative 3D conformal radiotherapy or VMAT","volume":"7","author":"Regnier","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2021.11.002_bib0290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13014-020-01597-1","article-title":"Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit","volume":"15","author":"de Jong","year":"2020","journal-title":"Radiat Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:56Z","timestamp":1761136496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821002730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821002730"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rectal cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}